Our data revealed different kinds of monocyte subset alterations in patients with oropharyngeal cancer with different immunological consequences in view of monocytic PD-L1 expression and altered percentages of CD4+ effector and CD4+ effector memory T cells. Here, CD4 is linked to oropharynx cancer.